These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 399249)

  • 1. [Influence of cefaclor on experimental pyelonephritis (author's transl)].
    Ritzerfeld W
    Infection; 1979; 7 Suppl 6():615-6. PubMed ID: 399249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activity of cefaclor (author's transl)].
    Knothe H
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of urinary tract infections by cefaclor, with special reference to the antibody-coated bacteria (ACB) detected by the immunoenzyme technique].
    Yamamoto M; Murase T; Taguchi J; Miyake K
    Hinyokika Kiyo; 1983 Aug; 29(8):959-68. PubMed ID: 6426273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection.
    Rotschafer J; Crossley K; Zaske D; Viste R
    Urology; 1979 Sep; 14(3):233-6. PubMed ID: 384643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subinhibitory activity of cefaclor and cephalexin (author's transl)].
    Shah PM; Staszewski S
    Infection; 1979; 7 Suppl 6():543-6. PubMed ID: 399246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine.
    Silver MS; Counts GW; Zeleznik D; Turck M
    Antimicrob Agents Chemother; 1977 Nov; 12(5):591-6. PubMed ID: 921255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of tigemonam, a novel oral monobactam.
    Clark JM; Olsen SJ; Weinberg DS; Dalvi M; Whitney RR; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1987 Feb; 31(2):226-9. PubMed ID: 3551830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bactericidal activity of amoxicillin and cefaclor in an "in vitro" kinetic model (author's transl)].
    Pothier P; Kazmierczak A; Siebor E; Gaillard MC; Pechinot A
    Ann Microbiol (Paris); 1981; 132(3):293-306. PubMed ID: 7027869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of cefaclor versus amoxicillin in urinary tract infections (author's transl)].
    Naber K; Kaldewey W
    Infection; 1979; 7 Suppl 6():617-21. PubMed ID: 399250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)].
    Lode H; Köppe P; Stahlmann R
    Infection; 1979; 7 Suppl 6():600-5. PubMed ID: 551086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)].
    Schassan HH
    Infection; 1979; 7 Suppl 6():527-31. PubMed ID: 399243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
    Leveque B; Lambert-Zechovsky N; Cathlin C
    Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
    [No Abstract]   [Full Text] [Related]  

  • 13. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Han SB; Lee SC; Lee SY; Jeong DC; Kang JH
    BMC Infect Dis; 2015 Oct; 15():414. PubMed ID: 26464143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Review [new antibiotics series V]: cefaclor (author's transl)].
    Fujii R
    Jpn J Antibiot; 1982 Mar; 35(3):714-23. PubMed ID: 7047791
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of two trimethoprim-sulphonamide combinations in experimental pyelonephritis in the rat.
    Ritzerfeld W
    Infection; 1979; 7 Suppl 4():S342-4. PubMed ID: 389811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antibacterial efficacy of cefaclor against bacteria resistant to ampicillin, tetracycline and co-trimoxazole (author's transl)].
    Machka K
    Infection; 1979; 7 Suppl 6():536-9. PubMed ID: 399244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
    Magni L; Lionell C
    Scand J Infect Dis Suppl; 1990; 74():185-9. PubMed ID: 2097707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of treatment with cefaclor, a new oral cephalosporin].
    Fortschr Med; 1979 Oct; 97(38):1709-10. PubMed ID: 511065
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory and clinical studies of cefaclor in Japan.
    Fujii R
    Postgrad Med J; 1979; 55 Suppl 4():88-92. PubMed ID: 398486
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefaclor versus ampicillin for outpatient treatment of urinary tract infections.
    Baraff LJ; Ablon WD
    Am J Emerg Med; 1984 Jul; 2(4):327-30. PubMed ID: 6394004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.